91ɫƵ

header-logo
Hero Image
Ocular Gene Therapy Laboratory

About the Ocular Gene Therapy Laboratory (OGTL) at the 91ɫƵ

Designing The Next Generation Of Gene Therapy Treatments

Founded in 2016 by Daniel M. Lipinski, DPhil, the Ocular Gene Therapy Laboratory (OGTL) aims to develop broadly applicable gene-based therapeutics to prevent human blindness arising from neurodegenerative or vascular diseases affecting the retina. Consisting of faculty, students and staff from a diverse range of academic backgrounds, the OGTL laboratory takes a highly multidisciplinary and collaborative approach toward research, working with basic science and clinical investigators worldwide to identify novel therapies for currently untreatable conditions that result in vision loss in humans.   Learn More
OGTL Team Photo 2022_Intro Component New v2
OGTL People Image Card

People

The OGTL succeeds because of the people who make up our program.

Meet our team
OGTL Research Image Card

Research

Our research focuses on developing broadly applicable gene-based therapeutics to prevent human blindness arising from neurodegenerative or vascular diseases affecting the retina.

Find out more about our research
OGTL News Image Card

Awards

We are proud of the recognition our team receives for the trailblazing work they do.

View our accomplishments
OGTL Careers Image Card

Careers

Interested in joining our team? We’d love to hear from you.

View resources for interested candidates